Global Active Pharmaceutical Ingredients/API Market 2017-2021: Increasing Uptake of Biopharmaceuticals / Growing Importance of Generics / Increasing Incidence of Chronic Diseases

Dublin, Jan. 17, 2017 -- Research and Markets has announced the addition of the "Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021" report to their offering.

The Active Pharmaceutical Ingredients Market in Terms of Value is Expected to Reach USD 213.97 Billion by 2021 from USD 157.95 Billion in 2016, Growing at a CAGR of 6.3% from 2016 to 2021

Market growth is driven by the increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals.

Furthermore, emerging biosimilars market, increasing scope for HPAPIs, emerging markets and emerging technologies have opened an array of opportunities for the growth of the market. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries may restrain the growth of this market.

For instance, in 2008, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, launched the Jan Aushadhi Scheme (Public Medicine Scheme) for providing quality medicines to the masses at affordable prices. Under this initiative, the government set up Jan Aushadhi stores to provide generic drugs to patients.

Similarly, The European Union's decentralized procedure (DCP) for drug approval is an effective system for cross-border collaboration on the authorization of medicines. This is being used as a model for a number of new global initiatives in the harmonization of pharmaceutical regulatory standards. The implementation of such standards in turn is expected to drive the adoption of generic drugs.

Emerging biosimilars market, increasing scope for HPAPIs, emerging markets and emerging technologies have opened an array of opportunities for the active pharmaceutical ingredients market. However, factors such as a stringent regulatory requirements and unfavorable drug price control policies across various countries may restrain the growth of this market.

Market Dynamics

Drivers

• Increasing Incidence of Chronic Diseases
• Rising Prevalence of Cancer
• Technological Advancements in Api Manufacturing
• Growing Importance of Generics
• Rapidly Increasing Geriatric Population
• Increase in Abbreviated New Drug Applications (ANDA)
• Increasing Uptake of Biopharmaceuticals

Restraints

• Stringent Regulatory Requirements
• Unfavorable Drug Price Control Policies Across Various Countries

Opportunities

• Emerging Biosimilars Market
• Increasing Scope for High-Potency Active Pharmaceutical Ingredients
• Emerging Markets
• Emerging Technologies

Challenges

• Product Differentiation
• High Manufacturing Costs

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Active Pharmaceutical Ingredients Market, by Type

7 Active Pharmaceutical Ingredients Market, by Type of Manufacturer

8 Active Pharmaceutical Ingredients Market, by Type of Synthesis

9 Active Pharmaceutical Ingredients Market, by Type of Drug

10 Active Pharmaceutical Ingredients Market, by Therapeutic Application

11 Active Pharmaceutical Ingredients Market, by Region

12 Competitive Landscape

13 Company Profiles

• Abbvie Inc.
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Eli Lilly and Company
• Glaxosmithkline Plc
• Merck & Co., Inc.
• Novartis International AG
• Pfizer, Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/8wh4m7/active

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Pharmaceuticals, Drug Discovery